In CD8-depleted mice, tumor growth in the NDV-MIP3α-treated mice recovered to almost the same as in the PBS-treated mice, suggesting the CD8-dependent immunity plays a vital role in the antitumor effect. This evidence concerns the gene CD8A and neoplasm.